Detalhe da pesquisa
1.
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.
Cell
; 185(5): 872-880.e3, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35123650
2.
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
Clin Infect Dis
; 75(1): e1028-e1036, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35022711
3.
Validation of digital droplet PCR assays for cell-associated HIV-1 DNA, HIV-1 2-LTR circle, and HIV-1 unspliced RNA for clinical studies in HIV-1 cure research.
J Clin Virol
; 170: 105632, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38113685
4.
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity.
J Clin Virol
; 143: 104945, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34450558
5.
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses.
bioRxiv
; 2021 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34931192
6.
Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates.
medRxiv
; 2021 Jun 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34100024